• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Avanir Pharmaceuticals Inc

+ Add to Watchlist


16.8500 USD 0.1400 0.82%

As of 20:10:00 ET on 12/19/2014.

Company Profile for Avanir Pharmaceuticals Inc (AVNR)

Avanir Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. The Company develops treatments for pseudobulbar affect, diabetic peripheral neuropathic pain, and other conditions. AVANIR out-licensed its moniclonal antibodies, and produces an over-the-counter treatment for cold sores.

Contact Information

Avanir Pharmaceuticals Inc

101 Enterprise
Suite 300
Aliso Viejo, CA 92656
United States
Phone: 1-949-389-6700

Key Executives for Avanir Pharmaceuticals Inc (AVNR)

Keith A KatkinPresident/CEORohan PalekarSenior VP/Chief Commercial Ofcr
Gregory J Flesher "Greg"Senior VP:Corporate Dev/Chief Bus OfcrJoao SiffertSenior VP:R&D/Chief Scientific Ofcr
Christine G OcampoVP:Finance/Chief Acctg Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil